109 related articles for article (PubMed ID: 9757197)
1. [Results of clinical study with epirubicin hydrochloride injectable solution in hepatoma].
Monden M; Nakamura H; Yayoi E; Monden T; Ohi H; Arisawa J; Masuzawa M; Shimizu T; Tomono N; Seki K; Nakao N; Todo A; Inoue Y; Sakon M; Ohsaki Y; Hosoki T
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1713-9. PubMed ID: 9757197
[TBL] [Abstract][Full Text] [Related]
2. [Results of clinical study with epirubicin hydrochloride injectable solution for superficial bladder cancer. IMI28 Injectable Solution Study Group for Superficial Bladder Cancer].
Kotake T; Koyanagi T; Akaza H; Shimazaki J; Ito H; Hosaka M; Okajima E; Saito Y; Miyanaga N; Kuroda M; Hirao Y
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1189-95. PubMed ID: 9679582
[TBL] [Abstract][Full Text] [Related]
3. [Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer].
Koyama H; Adachi I; Tajima T; Kanda K; Yoshida M; Miura S; Nakao K; Kikkawa N; Takai S; Toge T; Tamura K; Inaji H; Shiba E
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1721-9. PubMed ID: 9757198
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y
Oncology; 2007; 72(3-4):188-93. PubMed ID: 18097170
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
6. [Effect on hepatic function of hepatic artery infusion chemotherapy using epirubicin and mitoxantrone for advanced hepatocellular carcinoma].
Murata T; Nasu R; Kimura H; Uokawa K; Nagata K; Akagi K; Tanaka Y
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1707-11. PubMed ID: 9757196
[TBL] [Abstract][Full Text] [Related]
7. [Intra-arterial administration of epirubicin in the treatment of non-resectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma].
Nagasue N; Yukaya H; Okamura J; Kuroda C; Kubo Y; Hirai K; Tanikawa K; Okita K; Ando K; Tamura K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2786-92. PubMed ID: 3019251
[TBL] [Abstract][Full Text] [Related]
8. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
Akutsu M; Kano Y; Ogawa M; Miura A; Hirano M; Masaoka T; Tatsumi N
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1867-76. PubMed ID: 11729479
[TBL] [Abstract][Full Text] [Related]
9. Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma.
Higashi S; Tabata N; Kondo KH; Maeda Y; Shimizu M; Nakashima T; Setoguchi T
J Pharmacol Exp Ther; 1999 May; 289(2):816-9. PubMed ID: 10215657
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.
Zhu AX; Fuchs CS; Clark JW; Muzikansky A; Taylor K; Sheehan S; Tam K; Yung E; Kulke MH; Ryan DP
Oncologist; 2005; 10(6):392-8. PubMed ID: 15967833
[TBL] [Abstract][Full Text] [Related]
11. A case of hepatocellular carcinoma effectively treated with epirubicin aqueous vesicles in monodispersed iodized poppy-seed oil microdroplets.
Higashi S; Maeda Y; Kai M; Kitamura T; Tsubouchi H; Tamura S; Setoguchi T
Hepatogastroenterology; 1996; 43(12):1427-30. PubMed ID: 8975943
[TBL] [Abstract][Full Text] [Related]
12. Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
Lin ZY; Chuang WL; Chuang YH; Yu ML; Hsieh MY; Wang LY; Tsai JF
J Gastroenterol Hepatol; 2006 Feb; 21(2):398-405. PubMed ID: 16509865
[TBL] [Abstract][Full Text] [Related]
13. Epirubicin pharmacokinetics after intrahepatic arterial and intraperitoneal administration.
Strocchi E; Camaggi CM; Rossi AP; Angelelli B; Comparsi R; Franchini A; Del Prete P; Cola B; Pannuti F
Drugs Exp Clin Res; 1985; 11(4):295-301. PubMed ID: 3013561
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of treatment with frequent and low-dose epirubicin in two cases of pulmonary metastases after surgery of liver cancer].
Nakao A; Sato S; Nakajima A; Nabeyama A; Okada Y; Sakagami K
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1831-4. PubMed ID: 7574817
[TBL] [Abstract][Full Text] [Related]
15. [Early phase II clinical trial of amrubicin hydrochloride in patients with malignant lymphoma].
Masaoka T; Ogawa M; Inoue K; Sanpi K; Kuraishi Y; Toki H; Tamura K; Takagi T; Shibata A; Hirano M; Ezaki K; Shirakawa S; Matsuda T; Kimura I
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1857-65. PubMed ID: 11729478
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of arterial infusion chemotherapy with neocarzinostatin on inoperable hepatoma].
Sasaki Y; Fujita S; Yoshioka H; Takimoto C; Mitsutani N; Koizumi T
Gan To Kagaku Ryoho; 1982 May; 9(5):898-905. PubMed ID: 6307185
[TBL] [Abstract][Full Text] [Related]
17. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic arterial infusion chemotherapy (anthracycline)].
Yoshikawa M; Ebara M; Saisho H; Ueda S
Nihon Rinsho; 2001 Oct; 59 Suppl 6():612-6. PubMed ID: 11762022
[No Abstract] [Full Text] [Related]
19. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications].
Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis.
Daniele B; De Vivo R; Perrone F; Lastoria S; Tambaro R; Izzo F; Fiore F; Vallone P; Pignata S
Anticancer Res; 2000; 20(2B):1249-51. PubMed ID: 10810429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
